| UniProt ID | NIF3L_HUMAN | |
|---|---|---|
| UniProt AC | Q9GZT8 | |
| Protein Name | NIF3-like protein 1 {ECO:0000305|PubMed:11124544} | |
| Gene Name | NIF3L1 {ECO:0000312|HGNC:HGNC:13390} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 377 | |
| Subcellular Localization | Cytoplasm . Nucleus . Interaction with COPS2 may regulate localization to the nucleus. | |
| Protein Description | May function as a transcriptional corepressor through its interaction with COPS2, negatively regulating the expression of genes involved in neuronal differentiation.. | |
| Protein Sequence | MLSSCVRPVPTTVRFVDSLICNSSRSFMDLKALLSSLNDFASLSFAESWDNVGLLVEPSPPHTVNTLFLTNDLTEEVMEEVLQKKADLILSYHPPIFRPMKRITWNTWKERLVIRALENRVGIYSPHTAYDAAPQGVNNWLAKGLGACTSRPIHPSKAPNYPTEGNHRVEFNVNYTQDLDKVMSAVKGIDGVSVTSFSARTGNEEQTRINLNCTQKALMQVVDFLSRNKQLYQKTEILSLEKPLLLHTGMGRLCTLDESVSLATMIDRIKRHLKLSHIRLALGVGRTLESQVKVVALCAGSGSSVLQGVEADLYLTGEMSHHDTLDAASQGINVILCEHSNTERGFLSDLRDMLDSHLENKINIILSETDRDPLQVV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 82 (in isoform 2) | Ubiquitination | - | 7.55 | 21890473 | |
| 101 | Acetylation | PPIFRPMKRITWNTW CCCCCCCCCCCCCCH | 43.24 | 25953088 | |
| 104 | Phosphorylation | FRPMKRITWNTWKER CCCCCCCCCCCHHHH | 19.39 | 24719451 | |
| 109 | Acetylation | RITWNTWKERLVIRA CCCCCCHHHHHHHHH | 30.80 | 19608861 | |
| 109 | Ubiquitination | RITWNTWKERLVIRA CCCCCCHHHHHHHHH | 30.80 | 21890473 | |
| 109 (in isoform 1) | Ubiquitination | - | 30.80 | 21890473 | |
| 109 | Ubiquitination | RITWNTWKERLVIRA CCCCCCHHHHHHHHH | 30.80 | 21890473 | |
| 124 | Phosphorylation | LENRVGIYSPHTAYD HHHCCCCCCCCCHHH | 15.38 | - | |
| 125 | Phosphorylation | ENRVGIYSPHTAYDA HHCCCCCCCCCHHHC | 14.32 | - | |
| 130 | Phosphorylation | IYSPHTAYDAAPQGV CCCCCCHHHCCCCCH | 13.79 | 25839225 | |
| 143 | Ubiquitination | GVNNWLAKGLGACTS CHHHHHHHCCCCCCC | 53.12 | - | |
| 157 | Ubiquitination | SRPIHPSKAPNYPTE CCCCCCCCCCCCCCC | 72.77 | - | |
| 161 | Phosphorylation | HPSKAPNYPTEGNHR CCCCCCCCCCCCCCC | 15.52 | 26437602 | |
| 181 | Ubiquitination | NYTQDLDKVMSAVKG ECCCCHHHHHHHHCC | 47.32 | - | |
| 181 | Acetylation | NYTQDLDKVMSAVKG ECCCCHHHHHHHHCC | 47.32 | 25038526 | |
| 187 | Ubiquitination | DKVMSAVKGIDGVSV HHHHHHHCCCCCEEE | 50.28 | - | |
| 207 (in isoform 2) | Ubiquitination | - | 36.47 | 21890473 | |
| 215 (in isoform 2) | Ubiquitination | - | 31.09 | 21890473 | |
| 216 | Ubiquitination | INLNCTQKALMQVVD EECCCHHHHHHHHHH | 25.90 | - | |
| 219 | Sulfoxidation | NCTQKALMQVVDFLS CCHHHHHHHHHHHHH | 3.21 | 30846556 | |
| 226 | Phosphorylation | MQVVDFLSRNKQLYQ HHHHHHHHHCHHHHH | 33.53 | 21712546 | |
| 229 | Ubiquitination | VDFLSRNKQLYQKTE HHHHHHCHHHHHHHC | 40.34 | - | |
| 234 (in isoform 1) | Ubiquitination | - | 34.27 | 21890473 | |
| 234 | Ubiquitination | RNKQLYQKTEILSLE HCHHHHHHHCEECCC | 34.27 | 21890473 | |
| 234 | Ubiquitination | RNKQLYQKTEILSLE HCHHHHHHHCEECCC | 34.27 | 21890473 | |
| 242 | Ubiquitination | TEILSLEKPLLLHTG HCEECCCCCEEHHCC | 46.38 | 21890473 | |
| 242 (in isoform 1) | Ubiquitination | - | 46.38 | 21890473 | |
| 242 | Acetylation | TEILSLEKPLLLHTG HCEECCCCCEEHHCC | 46.38 | 25038526 | |
| 242 | 2-Hydroxyisobutyrylation | TEILSLEKPLLLHTG HCEECCCCCEEHHCC | 46.38 | - | |
| 255 | Phosphorylation | TGMGRLCTLDESVSL CCCCCCCCCCHHHHH | 41.66 | 23403867 | |
| 259 | Phosphorylation | RLCTLDESVSLATMI CCCCCCHHHHHHHHH | 19.37 | - | |
| 261 | Phosphorylation | CTLDESVSLATMIDR CCCCHHHHHHHHHHH | 22.90 | 19664994 | |
| 264 | Phosphorylation | DESVSLATMIDRIKR CHHHHHHHHHHHHHH | 21.69 | 23403867 | |
| 276 | Phosphorylation | IKRHLKLSHIRLALG HHHHHCHHHHHHHHH | 18.45 | 20068231 | |
| 348 | Phosphorylation | NTERGFLSDLRDMLD CCCCCHHHHHHHHHH | 32.13 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NIF3L_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NIF3L_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NIF3L_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-109, AND MASS SPECTROMETRY. | |